EGFR, epidermal growth factor receptor, 1956
N. diseases: 1394; N. variants: 183
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 7 | 55142377 | synonymous variant | G/A;T | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 7 | 55165388 | missense variant | G/A | snv | 2.0E-05 | 1.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.040 | 7 | 55191746 | missense variant | T/G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 7 | 55120299 | intron variant | G/A | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 7 | 55165394 | missense variant | G/A | snv | 8.0E-06 | 1.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.040 | 7 | 55174033 | missense variant | C/T | snv | 1.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 7 | 55156554 | missense variant | G/T | snv | 4.0E-06 | 1.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
1.000 | 0.040 | 7 | 55181318 | protein altering variant | -/GTC | ins |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
0.925 | 0.080 | 7 | 55174785 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms | 0.700 | 1.000 | 2 | 2005 | 2014 | |||||||
|
0.925 | 0.080 | 7 | 55170434 | missense variant | T/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.851 | 0.080 | 7 | 55200333 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.776 | 0.080 | 7 | 55181398 | missense variant | T/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.080 | 7 | 55191776 | missense variant | G/A | snv | 8.0E-06 | 7.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.925 | 0.080 | 7 | 55181314 | missense variant | G/A;C;T | snv | 2.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 7 | 55191741 | missense variant | G/A | snv | 4.8E-05 | 3.5E-05 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.851 | 0.080 | 7 | 55174777 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.120 | 7 | 55181312 | missense variant | GC/TT | mnv |
|
Neoplasms | 0.050 | 1.000 | 5 | 2006 | 2018 | ||||||||
|
0.807 | 0.120 | 7 | 55174014 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.720 | 1.000 | 3 | 2016 | 2018 | ||||||||
|
0.851 | 0.120 | 7 | 55174776 | missense variant | TT/CC | mnv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2015 | 2019 | ||||||||
|
0.851 | 0.120 | 7 | 55181370 | missense variant | G/A;C | snv | 0.52; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.790 | 0.120 | 7 | 55174029 | missense variant | G/A | snv | 7.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.120 | 7 | 55174015 | missense variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.120 | 7 | 55155928 | missense variant | G/A | snv | 1.6E-05 | 1.4E-05 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.776 | 0.120 | 7 | 55019062 | 5 prime UTR variant | G/C;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.763 | 0.160 | 7 | 55181312 | missense variant | G/T | snv |
|
Neoplasms | 0.050 | 1.000 | 5 | 2006 | 2018 |